Identification of a highly promiscuous and an HLA allele-specific T- cell epitope in the birch major allergen Bet v 1: HLA restriction, epitope mapping and TCR sequence comparisons

Clinical and Experimental Allergy

Volumn 29, Issue 4, 1999, Pages 478-487

  Friedl Hajek, R ^a   Spangfort, M D ^b   Schou, C ^b   Breiteneder, H ^a   Yssel, H ^c   Van Neerven, R J Joost ^b  

^a Dept of Gen and Exp Pathology ^*  (Austria)

^b ALK ABELLÓ   (Denmark)

^c INSERM   (France)

Author keywords

Immunotherapy; MHC; T lymphocyte; T cell receptors

Indexed keywords

POLLEN ANTIGEN; T LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; ATOPY; CONTROLLED STUDY; HELPER CELL; HLA SYSTEM; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALLELES; ALLERGENS; ANTIGEN PRESENTATION; BASE SEQUENCE; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; GENES, MHC CLASS II; HUMANS; MOLECULAR SEQUENCE DATA; PLANT PROTEINS; RECEPTORS, ANTIGEN, T-CELL;

EID: 0032935079     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00489.x     Document Type: Article

References (35)

1. 1 Wierenga EA, Snoek M, de Groot CJ, et al. Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990; 144:4651 -6.
2. 2 Kay AB, Ying S, Varney V, et al. Messenger RNA expression of the cytokine gen cluster, interleukin 3 (IL-3), IL4, IL5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173:775-8.
3. 3 Robinson DS, Hamid Q, Ying S, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
4. 4 Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation:relationship to tissue cosinophilia. J Immunol 1992; 148:2390-4.
5. 5 Davies MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988; 334:395-402.
6. 6 Garcia KC, Degano M, Stanfield RL, et al. An ab T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Sci 1996; 274:209-19.
7. 7 Rock EP, Sibbald PR, Davis MM, Chien Y. CDR3 length in antigen-specific immune receptors. J Exp Med 1994; 179: 323-8.
8. 8 Del Simonian H, Sugita M, Glass DN, et al. Clonal V alpha 12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients. J Exp Med 1993; 177:1623-31.
9. 9 Henwood J, Loveridge J, Bell JI, Gaston JS. Restricted T cell receptor expression by human T cell clones specific for mycobacterial 65-kDa heat-shock protein: selective in vivo expansion of T cells bearing defined receptors. Eur J Immunol 1993; 23:1256-65.
10. 10 Lannes-Viera J, Goudable B, Drexler K, et al. Encephalitogenic, myelin basic protein-specific T cells from naive rat thymus: preferential use of the T cell receptor V beta 8.2 and expression of the CD4-CD8-phenotype. Eur J Immunol 1995; 25:611-6.
11. 11 van de Vijver C., Mertens N, van den Elsen P, Medaer R, Raus J, Zhang J. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 1995:25:958-68.
12. 12 Meinl E, Weber F, Drexler K, et al. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest 1993; 92:2633-43.
13. 13 Breiteneder H, Hajek R, Scheiner O, et al. Diversity of TCR-Vβ and TCR-Vβ sequences used by human T cell clones specific for a minimal epitope of Bet v 1, the major birch pollen allergen. Immunogenetics 1995; 42:53-8.
14. 14 Wedderburn LR, O'Hehir RE, Hewitt CRA, Lamb JR. Owen MJ. In vivo clonal dominance and limited T-cell receptor usage in human CD4+ T-cell recognition of house dust mite allergens. Proc Natl Acad Sci USA 1993; 90:8214-8.
15. 15 van Neerven RJJ, Ebner C, Yssel H, Kapsenberg ML, Lamb JR. T lymphocyte responses to allergens: epitope-specificity and clinical relevance. Immunol Today 1996; 17:526-32.
16. 16 Ipsen H, Lowenstein H. Isolation and immunochemical characterisation of the major allergen of birch pollen (Betula verrucosa). J Allergy Clin Immunol 1983; 72:150.
17. 17 Ipsen H, Wihl JA, Petersen BN, Lowenstein H. Specificity mapping of patients IgE response towards the tree pollen major allergens, Aln g 1, Bet v 1 and Cor a 1. Clin Exp Allergy 1992; 22:391-9.
18. 18 Breiteneder H, Ferreira F, Reikerstorfer A, et al. Complementary cDNA cloning and expression in Escherichia coli of Aln g 1, the major allergen in pollen of alder (Alnus glutinosa). J Allergy Clin Immunol 1992; 90:909-17.
19. 19 Breiteneder H, Ferreira F, Hoffmann-Sommergruber K, et al. Four recombinant isoforms of Cor a I, the major allergen of hazel pollen, show different IgE binding properties. Eur J Biochem 1993; 552:1-8.
20. 20 Breiteneder H, Pettenburger K, Bito A, et al. The gene coding for the major birch allergen, Bet v I, is highly homologous to a pea disease resistance response gene. EMBO J 1989; 8:1935.
21. 21 Larsen JN, Stroman P, Ipsen H. PCR based cloning and sequencing of isogenes encoding the tree pollen major allergen Car b 1 from Carpinus betulus, hornbeam. Mol Immunol 1992; 29:703-11.
22. 22 Gajhede M, Osmark P, Poulsen FM, et al. X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy. Nature Struct Biol 1996; 3:1040-5.
23. 23 van Neerven RJJ, Sparholt SH, Schou C, Larsen JN. Preserved epitope-specific T cell activation by recombinant Bet v 1-MBP fusion proteins. Clin exp Allergy 1998; 28:423-33.
24. 24 Moss PAH, Bell JI. Sequence analysis of the huma ab T-cell recptor CDR3 region. Immunogenetics 1995; 42:10-8.
25. 25 Marsh SGE, Bodmer JG. HLA class II region nucleotide sequences, 1995. Tissue Antigens 1995; 45:258-80.
26. 26 May E, Duchmann R, Ackermann B, Meyer zum Büschenfelde KH, Märker-Hermann E. TCR junctional regions from HLA-B27-restricted T cells and HLA-B27 binding peptidcs display conserved hydropathy profiles in the absence of primary sequence homology. Int Immunol 1996; 8:1815-23.
27. 27 Struyk L, Hawes GE, Haanen JBAG, de Vries RRP, van den Elsen P. Clonal dominance and selection for similar complementary determining region 3 motifs among T lymphocytes responding to the HLA-DR3 associated Mycobacterium leprae heat shock protein 65 kd peptide 3-13. Hum Immunol 1995; 44:220-7.
28. 28 Bowness P, Moss PAH, Rowland-Jones S, Bell JI, McMichael AJ. Coservation of T cell receptor usage by HLA-B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I restricted responses. Eur J Immunol 1993; 23:1417.
29. 29 Moss PAH, Rosenberg WMC, Zintzaras E, Bell JI. Extensive conservation of a and b chains of the human T cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci USA 1991; 88:8987.
30. 30 Brown LE, Jackson DC, Tribbick G, White D, Geyson HM. Extention of a minimal T cell determinant allows relaxation of the requirement for particular residues within the determinant. Int Immunol 1991; 3:1307.
31. 31 de Campos-Lima P, Levitsky V, Imreh MP, Gavioli R, Masucci MG. Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in responses to persisilent infection by Epstein-Barr virus. J Exp Med 1997; 186:83-9.
32. 32 Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-τ secretion in specific allergen stimulated T cell cultures. J Immunol 1995; 154:4187-94.
33. 33 Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993; 178:2123-30.
34. 34 Varney VA, Humid QA, Gaga M, et al. Influence of grass pollen immunothcrapy on cellular infiltration and cytokine mRNA expression during allergen-induced late phase cutaneous responses. J Clin Invest 1993; 92:644-51.
35. 35 Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunothcrapy. J Allergy Clin Immunol 1997; 99:254-60.